A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
Phase of Trial: Phase III
Latest Information Update: 14 Jun 2019
Price : $35 *
At a glance
- Drugs Furosemide (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors Cutanea Life Sciences
- 19 Nov 2018 Status changed from active, no longer recruiting to completed.
- 27 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 11 Sep 2017 Status changed from not yet recruiting to recruiting.